{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:06:21Z","timestamp":1792033581397,"version":"4.4.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2023-00218543"],"award-info":[{"award-number":["RS-2023-00218543"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00461958"],"award-info":[{"award-number":["RS-2024-00461958"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    GNE myopathy is a recessive autosomal disease caused by mutations in glucosamine (UDP-\n                    <jats:italic>N<\/jats:italic>\n                    -acetyl)-2-epimerase\/\n                    <jats:italic>N<\/jats:italic>\n                    -acetylmannosamine kinase (GNE), characterized by impaired sialic acid biosynthesis and the formation of rimmed vacuoles. Similar to other autophagic vacuolar myopathies, defective autophagy has been implicated in disease pathogenesis; however, the underlying molecular mechanisms remain poorly understood. By performing transcriptome analysis on two independent GNE myoblast models derived from human pluripotent stem cells, we identified multiple autophagy-related gene sets as pathogenic signatures of GNE myopathy. These predictions were biochemically validated using\n                    <jats:italic>Gne<\/jats:italic>\n                    -knockout C2C12 myoblasts. Mechanistically, our data reveal that aberrant activation of the noncanonical AKT\u2013mTORC1 pathway\u2014driven by excessive extracellular matrix production\u2014induces inhibitory phosphorylation of ULK1, thereby suppressing autophagy initiation. To identify therapeutic targets, we performed a transcriptome-based drug screen using gene signature reversal, which nominated copanlisib, an FDA-approved Pi3k inhibitor, as a promising candidate. Functional validation in human pluripotent stem cell-derived neuromuscular organoids demonstrated that copanlisib reactivates autophagy via restoration of ULK1 activity. Together, our findings uncover a mechanistic link between extracellular matrix dysregulation and impaired autophagy in GNE myopathy and highlight copanlisib as a potential therapeutic strategy.\n                  <\/jats:p>","DOI":"10.1038\/s12276-026-01701-7","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T09:15:01Z","timestamp":1775812501000},"page":"1187-1202","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Defective autophagy in GNE myopathy is rescued by inhibition of noncanonical Akt\u2013mTORC1 activation across multiple isogenic models"],"prefix":"10.1038","volume":"58","author":[{"given":"Dong-Woo","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Ji","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyuk","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jumee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9277-2662","authenticated-orcid":false,"given":"Hyuk-Jin","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"key":"1701_CR1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0022-510X(81)90067-8","volume":"51","author":"I Nonaka","year":"1981","unstructured":"Nonaka, I., Sunohara, N., Ishiura, S. & Satoyoshi, E. Familial distal myopathy with rimmed vacuole and lamellar (myeloid) body formation. J. Neurol. Sci. 51, 141\u2013155 (1981).","journal-title":"J. Neurol. Sci."},{"key":"1701_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/ng718","author":"I Eisenberg","year":"2001","unstructured":"Eisenberg, I. et al. The UDP-N-acetylglucosamine 2-epimerase\/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy. Nat. Genet. https:\/\/doi.org\/10.1038\/ng718 (2001).","journal-title":"Nat. Genet."},{"key":"1701_CR3","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000041631.28557.c6","author":"I Nishino","year":"2002","unstructured":"Nishino, I. et al. Distal myopathy with rimmed vacuoles is allelic to hereditary inclusion body myopathy. Neurology https:\/\/doi.org\/10.1212\/01.wnl.0000041631.28557.c6 (2002).","journal-title":"Neurology"},{"key":"1701_CR4","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1093\/glycob\/cwp176","volume":"20","author":"N Kurochkina","year":"2010","unstructured":"Kurochkina, N., Yardeni, T. & Huizing, M. Molecular modeling of the bifunctional enzyme UDP-GlcNAc 2-epimerase\/ManNAc kinase and predictions of structural effects of mutations associated with HIBM and sialuria. Glycobiology 20, 322\u2013337 (2010).","journal-title":"Glycobiology"},{"key":"1701_CR5","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1136\/jnnp-2013-307051","volume":"86","author":"I Nishino","year":"2015","unstructured":"Nishino, I., Carrillo-Carrasco, N. & Argov, Z. GNE myopathy: current update and future therapy. J. Neurol. Neurosurg. Psychiatry 86, 385\u2013392 (2015).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1701_CR6","doi-asserted-by":"publisher","first-page":"e2109","DOI":"10.1212\/WNL.0000000000006932","volume":"92","author":"H Lochm\u00fcller","year":"2019","unstructured":"Lochm\u00fcller, H. et al. A phase 3 randomized study evaluating sialic acid extended-release for GNE myopathy. Neurology 92, e2109\u2013e2117 (2019).","journal-title":"Neurology"},{"key":"1701_CR7","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ymgme.2017.04.010","volume":"122","author":"X Xu","year":"2017","unstructured":"Xu, X. et al. Safety, pharmacokinetics and sialic acid production after oral administration of N-acetylmannosamine (ManNAc) to subjects with GNE myopathy. Mol. Genet. Metab. 122, 126\u2013134 (2017).","journal-title":"Mol. Genet. Metab."},{"key":"1701_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-25510-9","author":"R Singh","year":"2018","unstructured":"Singh, R., Chaudhary, P. & Arya, R. Role of IGF-1R in ameliorating apoptosis of GNE deficient cells. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-018-25510-9 (2018).","journal-title":"Sci. Rep."},{"key":"1701_CR9","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M116.764597","author":"ND Pham","year":"2017","unstructured":"Pham, N. D. et al. Effects of altered sialic acid biosynthesis on N-linked glycan branching and cell surface interactions. J. Biol. Chem. https:\/\/doi.org\/10.1074\/jbc.M116.764597 (2017).","journal-title":"J. Biol. Chem."},{"key":"1701_CR10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.072066199","author":"M Schwarzkopf","year":"2002","unstructured":"Schwarzkopf, M. et al. Sialylation is essential for early development in mice. Proc. Natl Acad. Sci. USA https:\/\/doi.org\/10.1073\/pnas.072066199 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1701_CR11","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1172\/JCI30954","volume":"117","author":"B Galeano","year":"2007","unstructured":"Galeano, B. et al. Mutation in the key enzyme of sialic acid biosynthesis causes severe glomerular proteinuria and is rescued by N-acetylmannosamine. J. Clin. Invest. 117, 1585\u20131594 (2007).","journal-title":"J. Clin. Invest."},{"key":"1701_CR12","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s12017-012-8209-7","volume":"15","author":"I Sela","year":"2013","unstructured":"Sela, I. et al. Variable phenotypes of knockin mice carrying the M712T Gne mutation. Neuromolecular Med. 15, 180\u2013191 (2013).","journal-title":"Neuromolecular Med."},{"key":"1701_CR13","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3233\/JND-190461","volume":"7","author":"H Benyamini","year":"2020","unstructured":"Benyamini, H. et al. Upregulation of hallmark muscle genes protects Gne M743T\/M743T mutated knock-in mice from kidney and muscle phenotype. J. Neuromuscul. Dis. 7, 119\u2013136 (2020).","journal-title":"J. Neuromuscul. Dis."},{"key":"1701_CR14","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1152\/physiolgenomics.90219.2008","volume":"35","author":"MCV Malicdan","year":"2008","unstructured":"Malicdan, M. C. V., Noguchi, S., Hayashi, Y. K. & Nishino, I. Muscle weakness correlates with muscle atrophy and precedes the development of inclusion body or rimmed vacuoles in the mouse model of DMRV\/hIBM. Physiol. Genomics 35, 106\u2013115 (2008).","journal-title":"Physiol. Genomics"},{"key":"1701_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddm220","author":"MC Malicdan","year":"2007","unstructured":"Malicdan, M. C., Noguchi, S., Nonaka, I., Hayashi, Y. K. & Nishino, I. A Gne knockout mouse expressing human GNE D176V mutation develops features similar to distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy. Hum. Mol. Genet. https:\/\/doi.org\/10.1093\/hmg\/ddm220 (2007).","journal-title":"Hum. Mol. Genet."},{"key":"1701_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41536-022-00238-3","volume":"7","author":"RE Schmitt","year":"2022","unstructured":"Schmitt, R. E. et al. Myogenesis defects in a patient-derived iPSC model of hereditary GNE myopathy. NPJ Regen. Med. 7, 48 (2022).","journal-title":"NPJ Regen. Med."},{"key":"1701_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121419","volume":"282","author":"J-C Park","year":"2022","unstructured":"Park, J.-C. et al. Multiple isogenic GNE-myopathy modeling with mutation specific phenotypes from human pluripotent stem cells by base editors. Biomaterials 282, 121419 (2022).","journal-title":"Biomaterials"},{"key":"1701_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.10.026","author":"N Mizushima","year":"2011","unstructured":"Mizushima, N. & Komatsu, M. Autophagy: renovation of cells and tissues. Cell https:\/\/doi.org\/10.1016\/j.cell.2011.10.026 (2011).","journal-title":"Cell"},{"key":"1701_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2010.09.023","author":"G Kroemer","year":"2010","unstructured":"Kroemer, G., Marino, G. & Levine, B. Autophagy and the integrated stress response. Mol. Cell https:\/\/doi.org\/10.1016\/j.molcel.2010.09.023 (2010).","journal-title":"Mol. Cell"},{"key":"1701_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2013.09.004","author":"BA Neel","year":"2013","unstructured":"Neel, B. A., Lin, Y. & Pessin, J. E. Skeletal muscle autophagy: a new metabolic regulator. Trends Endocrinol. Metab. https:\/\/doi.org\/10.1016\/j.tem.2013.09.004 (2013).","journal-title":"Trends Endocrinol. Metab."},{"key":"1701_CR21","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1128\/MCB.06159-11","volume":"32","author":"S Alers","year":"2012","unstructured":"Alers, S., L\u00f6ffler, A. S., Wesselborg, S. & Stork, B. Role of AMPK\u2013mTOR\u2013Ulk1\/2 in the regulation of autophagy: cross talk, shortcuts, and feedbacks. Mol. Cell. Biol. 32, 2\u201311 (2012).","journal-title":"Mol. Cell. Biol."},{"key":"1701_CR22","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/ncb2152","volume":"13","author":"J Kim","year":"2011","unstructured":"Kim, J., Kundu, M., Viollet, B. & Guan, K.-L. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat. Cell Biol. 13, 132\u2013141 (2011).","journal-title":"Nat. Cell Biol."},{"key":"1701_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2009.10.008","author":"E Masiero","year":"2009","unstructured":"Masiero, E. et al. Autophagy is required to maintain muscle mass. Cell Metab. https:\/\/doi.org\/10.1016\/j.cmet.2009.10.008 (2009).","journal-title":"Cell Metab."},{"key":"1701_CR24","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1038\/cdd.2016.70","volume":"23","author":"E Fiacco","year":"2016","unstructured":"Fiacco, E. et al. Autophagy regulates satellite cell ability to regenerate normal and dystrophic muscles. Cell Death Differ. 23, 1839\u20131849 (2016).","journal-title":"Cell Death Differ."},{"key":"1701_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/nature16187","author":"L Garcia-Prat","year":"2016","unstructured":"Garcia-Prat, L. et al. Autophagy maintains stemness by preventing senescence. Nature https:\/\/doi.org\/10.1038\/nature16187 (2016).","journal-title":"Nature"},{"key":"1701_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-020-0251-4","author":"M Hargreaves","year":"2020","unstructured":"Hargreaves, M. & Spriet, L. L. Skeletal muscle energy metabolism during exercise. Nat. Metab. https:\/\/doi.org\/10.1038\/s42255-020-0251-4 (2020).","journal-title":"Nat. Metab."},{"key":"1701_CR27","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pathmechdis.2.010506.091842","author":"M Kundu","year":"2008","unstructured":"Kundu, M. & Thompson, C. B. Autophagy: basic principles and relevance to disease. Annu. Rev. Pathol. https:\/\/doi.org\/10.1146\/annurev.pathmechdis.2.010506.091842 (2008).","journal-title":"Annu. Rev. Pathol."},{"key":"1701_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2020.08.011","author":"JM Faustino Martins","year":"2020","unstructured":"Faustino Martins, J. M. et al. Self-Organizing 3D Human Trunk Neuromuscular Organoids. Cell Stem Cell https:\/\/doi.org\/10.1016\/j.stem.2020.08.011 (2020).","journal-title":"Cell Stem Cell"},{"key":"1701_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/humu.22583","author":"FV Celeste","year":"2014","unstructured":"Celeste, F. V. et al. Mutation update for GNE gene variants associated with GNE myopathy. Hum. Mutat. https:\/\/doi.org\/10.1002\/humu.22583 (2014).","journal-title":"Hum. Mutat."},{"key":"1701_CR30","doi-asserted-by":"crossref","unstructured":"Cho, A. & Noguchi, S. Autophagy in GNE myopathy. In Autophagy\u2014A Double-Edged Sword-Cell Survival or Death (ed. Bailly, Y.) Ch.7 (IntechOpen, 2013).","DOI":"10.5772\/55223"},{"key":"1701_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0058116","author":"H Li","year":"2013","unstructured":"Li, H. et al. Unfolded protein response and activated degradative pathways regulation in GNE myopathy. PLoS ONE https:\/\/doi.org\/10.1371\/journal.pone.0058116 (2013).","journal-title":"PLoS ONE"},{"key":"1701_CR32","doi-asserted-by":"publisher","first-page":"114958","DOI":"10.1016\/j.biopha.2023.114958","volume":"164","author":"T Zhang","year":"2023","unstructured":"Zhang, T. et al. Metformin protects fibroblasts from patients with GNE myopathy by restoring autophagic flux via an AMPK\/mTOR-independent pathway. Biomed. Pharmacother. 164, 114958 (2023).","journal-title":"Biomed. Pharmacother."},{"key":"1701_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2024.114118","author":"J Oswalia","year":"2024","unstructured":"Oswalia, J., Singh, S., Gautam, V. & Arya, R. Altered autophagic flux in GNE mutant cells of Indian origin: potential drug target for GNE myopathy. Exp. Cell Res. https:\/\/doi.org\/10.1016\/j.yexcr.2024.114118 (2024).","journal-title":"Exp. Cell Res."},{"key":"1701_CR34","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddx192","author":"A Cho","year":"2017","unstructured":"Cho, A. et al. Sialic acid deficiency is associated with oxidative stress leading to muscle atrophy and weakness in GNE myopathy. Hum. Mol. Genet. https:\/\/doi.org\/10.1093\/hmg\/ddx192 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"1701_CR35","doi-asserted-by":"publisher","DOI":"10.1177\/1756285609359546","author":"MC Malicdan","year":"2010","unstructured":"Malicdan, M. C., Noguchi, S. & Nishino, I. A preclinical trial of sialic acid metabolites on distal myopathy with rimmed vacuoles\/hereditary inclusion body myopathy, a sugar-deficient myopathy: a review. Ther. Adv. Neurol. Disord. https:\/\/doi.org\/10.1177\/1756285609359546 (2010).","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"1701_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-023-02850-y","author":"M Mori-Yoshimura","year":"2023","unstructured":"Mori-Yoshimura, M. et al. Efficacy confirmation study of aceneuramic acid administration for GNE myopathy in Japan. Orphanet J. Rare Dis. https:\/\/doi.org\/10.1186\/s13023-023-02850-y (2023).","journal-title":"Orphanet J. Rare Dis."},{"key":"1701_CR37","doi-asserted-by":"publisher","DOI":"10.3233\/JND-230029","author":"N Suzuki","year":"2023","unstructured":"Suzuki, N. et al. Phase II\/III study of aceneuramic acid administration for GNE myopathy in Japan. J Neuromuscul. Dis. https:\/\/doi.org\/10.3233\/JND-230029 (2023).","journal-title":"J Neuromuscul. Dis."},{"key":"1701_CR38","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-013-9655-6","author":"KA Patzel","year":"2014","unstructured":"Patzel, K. A. et al. Non-specific accumulation of glycosphingolipids in GNE myopathy. J. Inherit. Metab. Dis. https:\/\/doi.org\/10.1007\/s10545-013-9655-6 (2014).","journal-title":"J. Inherit. Metab. Dis."},{"key":"1701_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2012.01.031","author":"SA Sarver","year":"2012","unstructured":"Sarver, S. A. et al. Preparation and electrophoretic separation of BODIPY-Fl-labeled glycosphingolipids. J. Chromatogr. A https:\/\/doi.org\/10.1016\/j.chroma.2012.01.031 (2012).","journal-title":"J. Chromatogr. A"},{"key":"1701_CR40","doi-asserted-by":"publisher","DOI":"10.1096\/fj.07-8527rev","author":"P de Lange","year":"2007","unstructured":"de Lange, P. et al. Fuel economy in food-deprived skeletal muscle: signaling pathways and regulatory mechanisms. FASEB J. https:\/\/doi.org\/10.1096\/fj.07-8527rev (2007).","journal-title":"FASEB J."},{"key":"1701_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2020.06.030","author":"D Sebastian","year":"2020","unstructured":"Sebastian, D. & Zorzano, A. Self-eating for muscle fitness: autophagy in the control of energy metabolism. Dev. Cell https:\/\/doi.org\/10.1016\/j.devcel.2020.06.030 (2020).","journal-title":"Dev. Cell"},{"key":"1701_CR42","doi-asserted-by":"publisher","DOI":"10.1126\/science.aag3048","author":"DS Leeman","year":"2018","unstructured":"Leeman, D. S. et al. Lysosome activation clears aggregates and enhances quiescent neural stem cell activation during aging. Science https:\/\/doi.org\/10.1126\/science.aag3048 (2018).","journal-title":"Science"},{"key":"1701_CR43","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2015.1066957","author":"C Mauvezin","year":"2015","unstructured":"Mauvezin, C. & Neufeld, T. P. Bafilomycin A1 disrupts autophagic flux by inhibiting both V-ATPase-dependent acidification and Ca-P60A\/SERCA-dependent autophagosome-lysosome fusion. Autophagy https:\/\/doi.org\/10.1080\/15548627.2015.1066957 (2015).","journal-title":"Autophagy"},{"key":"1701_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/mus.26486","author":"S Chakravorty","year":"2019","unstructured":"Chakravorty, S. et al. Clinical utility of RNA sequencing to resolve unusual GNE myopathy with a novel promoter deletion. Muscle Nerve https:\/\/doi.org\/10.1002\/mus.26486 (2019).","journal-title":"Muscle Nerve"},{"key":"1701_CR45","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1146\/annurev.cellbio.22.010305.104315","volume":"22","author":"CM Nelson","year":"2006","unstructured":"Nelson, C. M. & Bissell, M. J. Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer. Annu. Rev. Cell Dev. Biol. 22, 287\u2013309 (2006).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"1701_CR46","doi-asserted-by":"publisher","first-page":"124","DOI":"10.4161\/auto.23323","volume":"9","author":"P-M Wong","year":"2013","unstructured":"Wong, P.-M., Puente, C., Ganley, I. G. & Jiang, X. The ULK1 complex: sensing nutrient signals for autophagy activation. Autophagy 9, 124\u2013137 (2013).","journal-title":"Autophagy"},{"key":"1701_CR47","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/ncb2757","volume":"15","author":"RC Russell","year":"2013","unstructured":"Russell, R. C. et al. ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase. Nat. Cell Biol. 15, 741\u2013750 (2013).","journal-title":"Nat. Cell Biol."},{"key":"1701_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-018-0924-8","volume":"17","author":"S-K Hong","year":"2018","unstructured":"Hong, S.-K. et al. Large-scale pharmacogenomics based drug discovery for ITGB3 dependent chemoresistance in mesenchymal lung cancer. Mol. Cancer 17, 1\u20137 (2018).","journal-title":"Mol. Cancer"},{"key":"1701_CR49","doi-asserted-by":"publisher","first-page":"4567","DOI":"10.1038\/s41388-020-1316-2","volume":"39","author":"O Kwon","year":"2020","unstructured":"Kwon, O. et al. Connectivity map-based drug repositioning of bortezomib to reverse the metastatic effect of GALNT14 in lung cancer. Oncogene 39, 4567\u20134580 (2020).","journal-title":"Oncogene"},{"key":"1701_CR50","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s12272-019-01176-3","volume":"42","author":"O-S Kwon","year":"2019","unstructured":"Kwon, O.-S., Kim, W., Cha, H.-J. & Lee, H. In silico drug repositioning: from large-scale transcriptome data to therapeutics. Arch. Pharm. Res. 42, 879\u2013889 (2019).","journal-title":"Arch. Pharm. Res."},{"key":"1701_CR51","doi-asserted-by":"publisher","first-page":"3663","DOI":"10.1093\/hmg\/ddn261","volume":"17","author":"I Eisenberg","year":"2008","unstructured":"Eisenberg, I. et al. Mitochondrial processes are impaired in hereditary inclusion body myopathy. Hum. Mol. Genet. 17, 3663\u20133674 (2008).","journal-title":"Hum. Mol. Genet."},{"key":"1701_CR52","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nrd.2016.245","volume":"16","author":"Y Shi","year":"2017","unstructured":"Shi, Y., Inoue, H., Wu, J. C. & Yamanaka, S. Induced pluripotent stem cell technology: a decade of progress. Nat. Rev. Drug Discov. 16, 115\u2013130 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1701_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2013.03.015","author":"P Castets","year":"2013","unstructured":"Castets, P. et al. Sustained activation of mTORC1 in skeletal muscle inhibits constitutive and starvation-induced autophagy and causes a severe, late-onset myopathy. Cell Metab. https:\/\/doi.org\/10.1016\/j.cmet.2013.03.015 (2013).","journal-title":"Cell Metab."},{"key":"1701_CR54","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200903131","author":"V Risson","year":"2009","unstructured":"Risson, V. et al. Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy. J. Cell Biol. https:\/\/doi.org\/10.1083\/jcb.200903131 (2009).","journal-title":"J. Cell Biol."},{"key":"1701_CR55","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1093\/annonc\/mdw282","volume":"27","author":"A Patnaik","year":"2016","unstructured":"Patnaik, A. et al. First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin\u2019s lymphomas. Ann. Oncol. 27, 1928\u20131940 (2016).","journal-title":"Ann. Oncol."},{"key":"1701_CR56","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.75.4648","author":"M Dreyling","year":"2017","unstructured":"Dreyling, M. et al. Phosphatidylinositol 3-kinase inhibition by copanlisib in relapsed or refractory indolent lymphoma. J. Clin. Oncol. https:\/\/doi.org\/10.1200\/JCO.2017.75.4648 (2017).","journal-title":"J. Clin. Oncol."},{"key":"1701_CR57","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1002\/ajh.25711","volume":"95","author":"M Dreyling","year":"2020","unstructured":"Dreyling, M. et al. Long-term safety and efficacy of the PI3K inhibitor copanlisib in patients with relapsed or refractory indolent lymphoma: 2-year follow-up of the CHRONOS-1 study. Am. J. Hematol. 95, 362\u2013371 (2020).","journal-title":"Am. J. Hematol."},{"key":"1701_CR58","doi-asserted-by":"publisher","first-page":"RP87081","DOI":"10.7554\/eLife.87081","volume":"12","author":"L Mavrommatis","year":"2023","unstructured":"Mavrommatis, L. et al. Human skeletal muscle organoids model fetal myogenesis and sustain uncommitted PAX7 myogenic progenitors. eLife 12, RP87081 (2023).","journal-title":"eLife"}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01701-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01701-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01701-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T02:18:28Z","timestamp":1778033908000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01701-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":58,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["1701"],"URL":"https:\/\/doi.org\/10.1038\/s12276-026-01701-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7441350\/v1","asserted-by":"object"}]},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"assertion":[{"value":"23 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}